Condition
Scoliosis Correction
Total Trials
5
Recruiting
2
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
P 2 (1)
P 4 (4)
Trial Status
Recruiting2
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06062550Phase 4Active Not RecruitingPrimary
Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery
NCT07217873Phase 2RecruitingPrimary
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
NCT05718544Phase 4CompletedPrimary
Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes
NCT06087510Phase 4RecruitingPrimary
Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes
NCT04791059Phase 4CompletedPrimary
Low-dose S-ketamine and Dexmedetomidine in Combination With Opioids for Postoperative Analgesia
Showing all 5 trials